Clinician Support Agent - San Francisco at iRhythm Technologies

San Francisco, California, United States

iRhythm Technologies Logo
Not SpecifiedCompensation
Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical DevicesIndustries

Requirements

Candidates should possess an associate degree and a minimum of one year of related customer service call center experience, or a high school diploma and a minimum of two years of customer service call center experience, preferably in the medical industry. Prior experience in an EKG interpretation setting is preferred, along with proficiency in medical terminology and technical skills with case management (CRM) systems and Microsoft Office, including Outlook, Microsoft Teams, and Microsoft Word. Knowledge of cardiology medical terminology and HIPAA guidelines is also required.

Responsibilities

As the Clinician Support Liaison, the agent will serve as the primary communicator between cardiac technicians and external accounts, including hospitals, clinicians, and patients, via phone, Outlook, ZioReports, and Salesforce. They will effectively communicate ECG abnormalities by adhering to physician notification protocols and notifying physicians/clinical personnel as required. The agent will perform account follow-ups for additional clinical information, verify process notification MDN criteria, update case status in case management ticket systems, foster communication with internal and external partners, meet performance metrics, and adhere to HIPAA guidelines. Additionally, they will undertake other duties as assigned, including attending in-office days at least two days a week in San Francisco, CA, and working alternating weekends and shifts.

Skills

Communication
Problem-solving
Customer service
Salesforce
Outlook
ZioReports

iRhythm Technologies

Advanced cardiac monitoring solutions provider

About iRhythm Technologies

iRhythm Technologies focuses on cardiac monitoring solutions, with its main product being the Zio Patch, a wearable device that tracks heart rhythms for up to 14 days. This extended monitoring helps healthcare providers detect irregular heart rhythms that shorter monitoring might miss, making it especially useful for patients at risk. The company serves both patients and healthcare providers, generating revenue by selling the Zio Patch and offering data analysis services to interpret the collected heart data. iRhythm aims to improve patient outcomes and streamline healthcare workflows in the cardiac health sector.

San Francisco, CaliforniaHeadquarters
2006Year Founded
$102.8MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Mental Health Support
Hybrid Work Options
Pet Insurance

Risks

Increased competition from emerging cardiac monitoring technologies threatens market share.
FDA warning letter may lead to regulatory scrutiny and potential fines.
Shareholder investigation could result in legal challenges and financial liabilities.

Differentiation

Zio Patch offers up to 14 days of uninterrupted cardiac monitoring.
iRhythm's Zio Patch is the smallest and least conspicuous cardiac diagnostic device.
The company provides data analysis services for actionable insights from Zio Patch data.

Upsides

Wearable health tech market growth aligns with iRhythm's business model.
Telehealth expansion increases demand for remote monitoring solutions like Zio Patch.
AI integration enhances arrhythmia detection accuracy in iRhythm's Zio Patch.

Land your dream remote job 3x faster with AI